Shares of CounterPath Corporation (NASDAQ:CPAH) (TSE:CCV) have been assigned a consensus broker rating score of 2.00 (Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a buy rating.

Analysts have set a 1 year consensus price target of $4.25 for the company and are forecasting that the company will post ($0.13) earnings per share for the current quarter, according to Zacks. Zacks has also given CounterPath Corporation an industry rank of 120 out of 265 based on the ratings given to related companies.

CPAH has been the topic of a number of recent research reports. Zacks Investment Research upgraded CounterPath Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, September 13th. ValuEngine downgraded CounterPath Corporation from a “hold” rating to a “sell” rating in a report on Friday, September 1st.

Shares of CounterPath Corporation (CPAH) traded down $0.17 during midday trading on Tuesday, hitting $2.53. The company had a trading volume of 8,900 shares, compared to its average volume of 3,972. CounterPath Corporation has a twelve month low of $1.75 and a twelve month high of $3.00.

TRADEMARK VIOLATION WARNING: This piece was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://theolympiareport.com/2017/11/21/zacks-counterpath-corporation-cpah-receives-consensus-recommendation-of-buy-from-brokerages.html.

CounterPath Corporation Company Profile

CounterPath Corporation designs, develops and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol (IP)-based networks.

Get a free copy of the Zacks research report on CounterPath Corporation (CPAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CounterPath Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CounterPath Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.